These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16578977)

  • 1. Antidepressant usage in the Canadian Forces.
    Gutschi LM; Vaillancourt R; Boddam R
    Mil Med; 2006 Feb; 171(2):107-11. PubMed ID: 16578977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.
    Sheehan DV; Keene MS; Eaddy M; Krulewicz S; Kraus JE; Carpenter DJ
    CNS Drugs; 2008; 22(11):963-73. PubMed ID: 18840035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyproheptadine for combat nightmares in post-traumatic stress disorder and dream anxiety disorder.
    Brophy MH
    Mil Med; 1991 Feb; 156(2):100-1. PubMed ID: 1900585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mental health treatment seeking by military members with posttraumatic stress disorder: findings on rates, characteristics, and predictors from a nationally representative Canadian military sample.
    Fikretoglu D; Brunet A; Guay S; Pedlar D
    Can J Psychiatry; 2007 Feb; 52(2):103-10. PubMed ID: 17375866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring patients on chronic treatment with antidepressants between 2003 and 2011: analysis of factors associated with compliance.
    Serna MC; Real J; Cruz I; Galván L; Martin E
    BMC Public Health; 2015 Nov; 15():1184. PubMed ID: 26611468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.
    Brady KT; Clary CM
    Compr Psychiatry; 2003; 44(5):360-9. PubMed ID: 14505296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insomnia, psychiatric disorders and suicidal ideation in a National Representative Sample of active Canadian Forces members.
    Richardson JD; Thompson A; King L; Corbett B; Shnaider P; St Cyr K; Nelson C; Sareen J; Elhai J; Zamorski M
    BMC Psychiatry; 2017 Jun; 17(1):211. PubMed ID: 28583100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antidepressants consumption in the global population in France].
    Olié JP; Elomari F; Spadone C; Lépine JP
    Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the protective effect of etazolate on memory impairment, anxiety- and depression-like behaviors induced by post traumatic stress disorder.
    Alzoubi KH; Al Subeh ZY; Khabour OF
    Brain Res Bull; 2017 Oct; 135():185-192. PubMed ID: 29107895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalance and determinants of antidepressant use among Canadian Forces members experiencing major depressive episodes.
    Sanyal C; Asbridge M; Kisely S; Sketris I; Andreaou P
    J Popul Ther Clin Pharmacol; 2011; 18(1):e54-64. PubMed ID: 21289379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of depression and prescriptions for antidepressants, Bella Coola Valley, 2001.
    Thommasen HV; Baggaley E; Thommasen C; Zhang W
    Can J Psychiatry; 2005 May; 50(6):346-52. PubMed ID: 15999951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic symptoms and health-related quality of life among treatment-seeking Canadian Forces personnel with PTSD.
    St Cyr K; McIntyre-Smith A; Contractor AA; Elhai JD; Richardson JD
    Psychiatry Res; 2014 Aug; 218(1-2):148-52. PubMed ID: 24745465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketamine's dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders.
    Glue P; Medlicott NJ; Harland S; Neehoff S; Anderson-Fahey B; Le Nedelec M; Gray A; McNaughton N
    J Psychopharmacol; 2017 Oct; 31(10):1302-1305. PubMed ID: 28441895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants].
    Leblé N; Radon L; Rabot M; Godart N
    Encephale; 2017 Feb; 43(1):62-68. PubMed ID: 27452149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obsessive-compulsive disorder has a reduced placebo (and antidepressant) response compared to other anxiety disorders: A meta-analysis.
    Sugarman MA; Kirsch I; Huppert JD
    J Affect Disord; 2017 Aug; 218():217-226. PubMed ID: 28477500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining the association between psychiatric illness and suicidal ideation in a sample of treatment-seeking Canadian peacekeeping and combat veterans with posttraumatic stress disorder PTSD.
    Richardson JD; St Cyr KC; McIntyre-Smith AM; Haslam D; Elhai JD; Sareen J
    Can J Psychiatry; 2012 Aug; 57(8):496-504. PubMed ID: 22854032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher costs and therapeutic factors associated with adherence to NCQA HEDIS antidepressant medication management measures: analysis of administrative claims.
    Robinson RL; Long SR; Chang S; Able S; Baser O; Obenchain RL; Swindle RW
    J Manag Care Pharm; 2006; 12(1):43-54. PubMed ID: 16420107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. America's medicated Army.
    Thompson M
    Time; 2008 Jun; 171(24):38-42. PubMed ID: 18605261
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of anxiety and depression in transplant patients: pharmacokinetic considerations.
    Crone CC; Gabriel GM
    Clin Pharmacokinet; 2004; 43(6):361-94. PubMed ID: 15086275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy of antidepressants in preventing relapse in anxiety disorders - a meta-analysis.
    Donovan MR; Glue P; Kolluri S; Emir B
    J Affect Disord; 2010 Jun; 123(1-3):9-16. PubMed ID: 19616306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.